Delivery Order SPE2DB24D9228-SPE2DB25FATHY
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. on August 5, 2025, for the supply of YF-VAX 1 dose vials with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order does not utilize a set-aside designation and represents a straightforward pharmaceutical procurement. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. on June 26, 2025, for the supply of YF-VAX 1 dose vials. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Illinois location with an ultimate completion date of July 18, 2025. This award utilizes a firm fixed-price contract type with no set-aside designation, allowing the vendor to compete...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for the supply of YF-VAX 1 dose vials. The contract is a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, and was executed on July 28, 2025. The award was issued without a set-aside designation, leveraging open competition. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,783.55 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 dose vials. The contract is a firm fixed-price delivery order with an ultimate completion date of September 24, 2025, and was awarded on September 3, 2025. This award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials on September 9, 2025. This firm fixed-price delivery order is part of DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at approximately $500 million through November 2026. The contract requires delivery to Park Ridge, Illinois, with an ultimate completion date of September 30, 2025. No...
- The Defense Logistics Agency awarded a delivery order valued at $2,226.84 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of September 29, 2025. This firm fixed-price delivery order was awarded on September 8, 2025, with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Park Ridge facility. The company has been registered in the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for YF-VAX 1 Dose Vials, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order was issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with DLA under the SPE2DB program, a $499.9 billion contract vehicle valid through November 2026 that enables the agency to procure pharmaceutical products and medical supplies for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $36,186.15 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 Dose Vials. The award, issued on July 29, 2025, with an ultimate completion date of August 19, 2025, utilizes firm fixed-price pricing and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,670.13 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 dose vials. The award, issued on September 19, 2025, carries an ultimate completion date of October 10, 2025, and utilizes firm fixed-price pricing with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 4, 2025, for YF-VAX 1 dose vials with a ceiling value of $1,670.13. This firm fixed-price delivery order is scheduled for ultimate completion by September 25, 2025, and carries no set-aside designation. The award represents a specific delivery under DMS Pharmaceutical Group's larger Indefinite Delivery...
- SPE2DB24D9228Indefinite Delivery Contract
- SPE2DB24D9228-SPE2DB25FATHYDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. on September 19, 2025, for the supply of YF-VAX 1 dose vials. This firm fixed-price delivery order is scheduled for ultimate completion by October 10, 2025, with performance taking place in Park Ridge, Illinois. The award was made without a set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the open market despite its status as a woman-owned small business. DMS Pharmaceutical Group Inc., based in Park Ridge, Illinois, is an established pharmaceutical wholesaler specializing in supplying comprehensive medical products to federal healthcare systems, with SAM.gov registration dating back to 2001. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at approximately $500 million and valid through November 2026. This IDC framework enables the DLA to issue firm fixed-price delivery orders for a broad range of pharmaceutical products supporting military healthcare facilities nationwide. YF-VAX, a yellow fever vaccine, represents one of many pharmaceutical items available through this comprehensive contract vehicle, which encompasses prescription medications, biologics, over-the-counter products, and medical consumables across multiple therapeutic categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/19/25 |